CAD 0.66
(-1.49%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | 2.55 Million USD | 194.3% |
2022 | 1.44 Million USD | -11.55% |
2021 | 1.63 Million USD | 269.3% |
2020 | -965.32 Thousand USD | 75.08% |
2019 | -3.87 Million USD | 22.03% |
2018 | -4.96 Million USD | -3477.58% |
2017 | -138.85 Thousand USD | 85.34% |
2016 | -947.17 Thousand USD | -100.2% |
2015 | -473.12 Thousand USD | 69.37% |
2014 | -1.54 Million USD | 52.96% |
2013 | -3.28 Million USD | -249.62% |
2012 | -939.12 Thousand USD | -20.88% |
2011 | -776.91 Thousand USD | -19.62% |
2010 | -649.5 Thousand USD | -96.56% |
2009 | -330.44 Thousand USD | -594.91% |
2008 | -47.55 Thousand USD | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q2 | 545.43 Thousand USD | 0.0% |
2024 Q3 | 127.57 Thousand USD | -76.61% |
2023 Q3 | 977.23 Thousand USD | 18.2% |
2023 FY | 4.25 Million USD | 194.3% |
2023 Q2 | 826.79 Thousand USD | -20.09% |
2023 Q1 | 1.03 Million USD | 453.83% |
2023 Q4 | 1.8 Million USD | 84.53% |
2022 Q1 | 486.61 Thousand USD | -67.89% |
2022 Q3 | 486 Thousand USD | 0.52% |
2022 Q4 | -292.42 Thousand USD | -160.17% |
2022 Q2 | 483.48 Thousand USD | -0.64% |
2022 FY | 1.44 Million USD | -11.55% |
2021 Q3 | 715.53 Thousand USD | 378.56% |
2021 FY | 1.63 Million USD | 269.3% |
2021 Q4 | 1.51 Million USD | 111.78% |
2021 Q1 | -987.06 Thousand USD | -861.91% |
2021 Q2 | -256.87 Thousand USD | 73.98% |
2020 FY | -965.32 Thousand USD | 75.08% |
2020 Q4 | -102.61 Thousand USD | 85.26% |
2020 Q2 | -597.5 Thousand USD | -234.57% |
2020 Q3 | -695.96 Thousand USD | -16.48% |
2020 Q1 | -178.59 Thousand USD | 58.83% |
2019 Q2 | -1.65 Million USD | 64.38% |
2019 Q4 | -433.82 Thousand USD | 50.2% |
2019 FY | -3.87 Million USD | 22.03% |
2019 Q1 | -4.65 Million USD | -229.71% |
2019 Q3 | -871.19 Thousand USD | 47.49% |
2018 Q3 | -125.94 Thousand CAD | -28.41% |
2018 FY | -4.96 Million USD | -3477.58% |
2018 Q4 | -1.41 Million USD | -1021.91% |
2018 Q2 | -98.07 Thousand USD | -33.7% |
2018 Q1 | -73.35 Thousand USD | 25.08% |
2017 Q3 | -1.64 Million USD | -964.15% |
2017 Q2 | -154.59 Thousand USD | -21.23% |
2017 Q1 | -127.52 Thousand USD | 66.51% |
2017 FY | -138.85 Thousand USD | 85.34% |
2017 Q4 | -97.91 Thousand USD | 94.05% |
2016 Q3 | -187.67 Thousand USD | 71.23% |
2016 FY | -947.17 Thousand USD | -100.2% |
2016 Q2 | -652.34 Thousand USD | -1060.29% |
2016 Q4 | -380.74 Thousand USD | -102.87% |
2016 Q1 | -56.22 Thousand CAD | -29.3% |
2015 Q1 | -203.67 Thousand USD | 0.97% |
2015 Q4 | -43.48 Thousand USD | -117.63% |
2015 Q3 | 246.56 Thousand USD | 175.85% |
2015 Q2 | -325.08 Thousand USD | -59.61% |
2015 FY | -473.12 Thousand USD | 69.37% |
2014 Q1 | -86.81 Thousand USD | -37.09% |
2014 FY | -1.54 Million USD | 52.96% |
2014 Q2 | -36.97 Thousand USD | 57.4% |
2014 Q3 | -178.01 Thousand USD | -381.39% |
2014 Q4 | -205.66 Thousand USD | -15.53% |
2013 Q1 | -165.67 Thousand USD | 2.99% |
2013 FY | -3.28 Million USD | -249.62% |
2013 Q4 | -63.32 Thousand USD | 97.8% |
2013 Q3 | -2.87 Million USD | -3744.9% |
2013 Q2 | -74.72 Thousand USD | 54.89% |
2012 Q3 | 1.1 Million USD | 358.6% |
2012 FY | -939.12 Thousand USD | -20.88% |
2012 Q2 | -425.73 Thousand USD | 72.53% |
2012 Q1 | -1.54 Million USD | -351.27% |
2012 Q4 | -170.78 Thousand USD | -115.51% |
2011 Q3 | -308.9 Thousand USD | -24.79% |
2011 Q4 | -343.38 Thousand USD | -11.16% |
2011 Q1 | -51.28 Thousand USD | 47.18% |
2011 FY | -776.91 Thousand USD | -19.62% |
2011 Q2 | -247.54 Thousand USD | -382.68% |
2010 Q3 | -467.33 Thousand USD | -556.2% |
2010 Q2 | -71.21 Thousand USD | -103.72% |
2010 Q1 | -34.95 Thousand USD | 53.97% |
2010 FY | -649.5 Thousand USD | -96.56% |
2010 Q4 | -97.09 Thousand USD | 79.22% |
2009 Q4 | -75.94 Thousand USD | 66.69% |
2009 Q1 | -8245.44 USD | -46.58% |
2009 FY | -330.44 Thousand USD | -594.91% |
2009 Q3 | -228 Thousand USD | -295.25% |
2009 Q2 | -57.68 Thousand USD | -599.61% |
2008 FY | -47.55 Thousand USD | 0.0% |
2008 Q4 | -5625.25 USD | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
Aion Therapeutic Inc. | -1.19 Million CAD | 314.696% |
Ayurcann Holdings Corp. | -3.25 Million CAD | 178.653% |
Blueberries Medical Corp. | -1.22 Million CAD | 308.461% |
The BC Bud Corporation | -1.22 Million CAD | 308.988% |
BioNxt Solutions Inc. | -6.36 Million CAD | 140.157% |
CordovaCann Corp. | -2.51 Million CAD | 201.766% |
Christina Lake Cannabis Corp. | -880.54 Thousand CAD | 390.379% |
Captor Capital Corp. | 655.2 Thousand CAD | -290.246% |
City View Green Holdings Inc. | -996.45 Thousand CAD | 356.603% |
1CM Inc. | 300.79 Thousand CAD | -750.067% |
Global Hemp Group Inc. | -551.7 Thousand CAD | 563.456% |
Greenway Greenhouse Cannabis Corporation | -3.87 Million CAD | 165.916% |
IM Cannabis Corp. | -12.17 Million CAD | 121.001% |
Lobe Sciences Ltd. | -3.35 Million CAD | 176.113% |
Maple Leaf Green World Inc. | -392.21 Thousand CAD | 751.917% |
Mountain Valley MD Holdings Inc. | -3.18 Million CAD | 180.255% |
Nextleaf Solutions Ltd. | 542.27 Thousand CAD | -371.522% |
Ovation Science Inc. | -764 Thousand CAD | 434.672% |
Pharmadrug Inc. | -1.33 Million CAD | 291.528% |
Captiva Verde Wellness Corp. | -1.14 Million CAD | 323.904% |
RAMM Pharma Corp. | -7.08 Million CAD | 136.083% |
RIV Capital Inc. | 1.78 Million CAD | -43.628% |
Revive Therapeutics Ltd. | -3.28 Million CAD | 177.812% |
Red White & Bloom Brands Inc. | -8.76 Million CAD | 129.159% |
SLANG Worldwide Inc. | -5.98 Million CAD | 142.712% |
1933 Industries Inc. | -9.34 Million CAD | 127.349% |
Red Light Holland Corp. | -6.44 Million CAD | 139.664% |
Top Strike Resources Corp. | -784.8 Thousand CAD | 425.805% |
Xebra Brands Ltd. | -1.55 Million CAD | 264.481% |
Adastra Holdings Ltd. | -1.79 Million CAD | 242.546% |